April 6, 2018 / 5:27 AM / 15 days ago

BRIEF-U.S. FDA Observes Alembic Pharma Failed To Review Any Unexplained Discrepancy On Inspection Of Co's Panelav Plant - CNBC TV18

April 6 (Reuters) -

* USFDA OBSERVES ALEMBIC PHARMA FAILED TO REVIEW ANY UNEXPLAINED DISCREPANCY AFTER INSPECTION OF CO’S PANELAV PLANT ON MARCH 12-20 -CNBC TV18

* USFDA OBSERVES ALEMBIC PHARMA EMPLOYEES NOT GIVEN TRAINING IN OPS THEY PERFORM AFTER INSPECTION OF CO’S PANELAV PLANT ON MARCH 12-20 -CNBC TV18

* USFDA OBSERVES ALEMBIC PHARMA HAS NO WRITTEN PROCEDURES FOR PRODUCTION & PROCESS CONTROLS-CNBC TV18 Source text: bit.ly/2uPxn19 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below